| |

|
- CLC
Recommends Development of Guidelines for Fertility Preservation Counseling
(January 21, 2005)
- CLC
Applauds Medicare Coverage of Smoking Cessation Counseling
(January 21, 2005)
- CLC
Comments on CY 2005 Physician Fee Schedule
(December 23, 2004)
- CLC
Urges Broad Coverage of Colorectal Cancer and Other Anticancer Drugs
(December 23, 2004)
- CLC
Commends CMS Decision to Expand Coverage of PET Scans
(December 1, 2004)
- CLC
Recommends Prompt Appointment of Director of Oncology Products Office
(November
5, 2004)
- CLC
Submits Comments on USP Draft Guidelines for Medicare Part D
(September 17, 2004)
- CLC
Comments on National Cancer Cooperative Groups' Report on Cancer Clinical
Research
(July 7, 2004)
- CLC
Urges Prompt Release by CMS of Medicare ASP Data
(July 7, 2004)
- CLC
Urges Coverage of Off-Label Uses of Cancer Drugs in Medicare Demonstration
Project
(April 26, 2004)
- CLC
Endorses McClellan to Head CMS
(March 5, 2004)
- CLC
Calls for Prompt Implementation of Oral Cancer Demonstration Project
(March 4, 2004)
- CLC
Urges Medicare Conferees to Approve Oral Drug Coverage
(November 6, 2003)
- CLC
Commends Senator Hatch for Leadership on Medicare Oral Drug Coverage
(October 23, 2003)
- CLC
Submits Comments on Proposed Rule on Payment Reform for Part B Drugs
(October 10, 2003)
- CLC
Submits Comments on Proposed Calendar Year 2004 Update of Hospital Outpatient
Prospective Payment System (HOPPS)
(October 6, 2003)
- Letter
To All Medicare Conferees Urging Oral Cancer Drug Transition Benefit
(September 24, 2003)
- Letter
to Representatives and Senators Identifying Flaws in Cancer Care Provisions
of Medicare Bills
(July 14, 2003)
- Letter
to Energy & Commerce Committee In Support of Balanced Cancer Care
Reform
(June 18, 2003)
- Cancer
Organizations Express Strong Support for Quality Cancer Care Preservation
Act
(April 7, 2003)
- CLC
Urges CMS to Abandon National Coverage Analysis Process for Cancer Drugs
(March 14, 2003)
- CLC
Hails Introduction of Access to Cancer Therapies Act in 108th Congress
(March 13, 2003)
- CLC
Recommends Changes in FDA Review of Cancer Therapies
(February 24, 2003)
- CLC
Takes Issue with CMS Policy on Medicare Coverage of New Therapies
(December 16, 2002)
- Letter
to CMS Administrator Scully Urging Changes to Proposed Rule Setting
2003 Outpatient Payment Rates
(October 8, 2002)
- Roll
Call Ad Urging Congressional Action on Access to Cancer Therapies Act
(October 8, 2002)
- Letter
to Entire Senate Endorsing Access to Cancer Therapies Act
(October 7, 2002)
- CLC
Applauds Introduction of Lifespan Respite Care Act of 2002
(October 4, 2002)
- Letter
to CMS Administrator Scully Re: Urging Assignment of High-Dose IL-2
Therapy to New DRG
(September 12, 2002)
- Letter
to CMS Administrator Scully Re: Program Memorandum on Self-Administered
Drugs
(July 11, 2002)
- CLC Urges Pass-Through Payment
for New Cancer Drugs
(May 31, 2002)
- CLC Urges President Bush
to Ensure Fair Medicare Payment for Cancer Care
(May 23, 2002)
- CLC Recommends Correction
in Payment Rate for Cancer Drugs Used in Hospital Outpatient Setting
(May 17, 2002)
- CLC Applauds Senate Committee's Review
of Mammography Service Issue
(May 8, 2002)
- CLC Endorses Legislation Requiring Coverage
of Colorectal Screening Services
(May 8, 2002)
- Comments
on March 27, 2002 Proposed Rule Re: "The Privacy Rule"
(April 26, 2002)
- CLC Urges Conference Action on Nursing
Shortage
(April 19, 2002)
- Letter to DEA Administrator Hutchinson
Commending Agency Action on Pain Medications
(February 22, 2002)
- Letter to Entire Senate
(Second Session) Urging Support for Access to Cancer Therapies Act
(February 21, 2002)
- Letter to Entire House of
Representatives (Second Session) Urging Support for Access to Cancer
Therapies Act
(February 21, 2002)
- Letter to Tommy Thompson Supporting
Continued Coverage of Clinical Trials by Medicare
(February 11, 2002)
- Letter to Energy & Commerce,
Ways & Means & Finance Committees Re Medicare Reimbursement
for Cancer Drugs
(December 6, 2001)
- Senior Groups Join CLC in
Letter to Congress Endorsing the Access to Cancer Therapies Act
(November 27, 2001)
- Letter to All Members of
Ways & Means, Energy & Commerce and Senate Finance Committee
Regarding Medicare Payment for Physician-Administered Drugs
(October 19, 2001)
- Letter to Senators Harkin and Specter Regarding
FY 2002 NIH Funding Increase
(October 4, 2001)
- Letter to CMS Regarding Hospital
Outpatient Prospective Payment System Pass-Through Payments
(October 3, 2001)
- Letter to Representative Frank Wolf
Urging Balanced Approach to the Regulation of Pain Medications
(September 19, 2001)
- Letter to Senator Edward M. Kennedy
Urging Balanced Approach to the Regulation of Pain Medications
(September 19, 2001)
- Letter to Entire House of
Representatives Urging Cosponsorship of Access to Cancer Therapies Act
of 2001
(September 6, 2001)
- Letter to CMS Administrator
Scully Re: Reimbursement for Injectable Drugs
(August 28, 2001)
- CLC Endorses Dr. Richard Pazdur for FDA
Commissioner
(July 12, 2001)
- Letter to Rep. Allen Re: FDA Approval
Process
(July 10, 2001)
- Letter to Sens. McCain, Kennedy
and Edwards Applauding Introduction of Patients' Bill of Rights
(June 13, 2001)
- Letter to Senators Urging Co-Sponsorship
of the Access to Cancer Therapies Act, S. 913
(June 12, 2001)
- Letter to Senate Co-Sponsors
Applauding Introduction of the Access to Cancer Therapies Act, S. 913
(June 12, 2001)
- Letter to Tommy Thompson Applauding Expeditious
Approval of New Cancer Therapy
(May 31, 2001)
- Letter to Representative
Pryce Applauding Introduction of the Access to Cancer Therapies Act
of 2001
(April 25, 2001)
- Comments on Medical Records Privacy
Regulations
(March 30, 2001)
![]()
What's New | About
CLC | Policy Issues |
Participants' Login
Home | Sitemap | Contact Info
Copyright
© 2001-2002 Cancer Leadership Council. All rights reserved.
Please send comments and suggestions to webmaster@cancerleadership.org.
|
 |